P254 Ivacaftor treatment in patients with severe lung disease carrying CFTR mutations with residual function.

Saved in:
Bibliographic Details
Title: P254 Ivacaftor treatment in patients with severe lung disease carrying CFTR mutations with residual function.
Authors: Salvatore, D. (AUTHOR), Braggion, C. (AUTHOR), Calderazzo, M.A. (AUTHOR), Cresta, F. (AUTHOR), Majo, F. (AUTHOR), Messore, B. (AUTHOR), Pisi, G. (AUTHOR), Pizzamiglio, G. (AUTHOR), Biglia, C. (AUTHOR), Botti, M. (AUTHOR), Caloiero, M. (AUTHOR), Civati, E. (AUTHOR), Colangelo, C. (AUTHOR), De Gregorio, F. (AUTHOR), Francalanci, M. (AUTHOR), Longo, F. (AUTHOR), Terlizzi, V. (AUTHOR)
Source: Journal of Cystic Fibrosis. 2019 Supplement 1, Vol. 18, pS128-S129. 2p.
Database: Academic Search Ultimate
Description
ISSN:15691993
DOI:10.1016/S1569-1993(19)30547-8